Severe allergic asthma: Does alexithymia interfere with omalizumab treatment outcome?

Alexithymia is among psychological factors reported to interfere with asthma management. Severe allergic asthma (SAA) is characterized by uncontrolled asthma despite maximal standard pharmacological treatment which can benefit from an add-on treatment with Omalizumab, an anti-IgE monoclonal antibody...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Asian Pacific journal of allergy and immunology 2023-03, Vol.41 (1), p.53-59
Hauptverfasser:	Liotta, Marta, Liotta, Marco, Saitta, Salvatore, Ricciardi, Luisa
Format:	Artikel
Sprache:	eng
Schlagworte:	Affective Symptoms - drug therapy Affective Symptoms - etiology Alexithymia Asthma Asthma - drug therapy Drug therapy Emotions Female Humans Immunoglobulin E Immunosuppressive Agents Male Monoclonal antibodies Omalizumab - therapeutic use Quality of Life Questionnaires Statistical analysis Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!